Offer - Urjas Oil for just ₹ 1
Symbiva 200 Octacap is a prescription medicine that is available as a Capsule. Asthma are some of its major therapeutic uses. Other than this, Symbiva 200 Octacap has some other therapeutic uses, which have been discussed ahead.
The right dosage of Symbiva 200 Octacap depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Symbiva 200 Octacap also has some side effects, the most common being Nasopharyngitis, Headache, Back Pain. Besides the aforementioned side effects, there are other adverse effects of Symbiva 200 Octacap as well, which are listed below. Usually, these side effects of Symbiva 200 Octacap go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Symbiva 200 Octacap has a Moderate effect for pregnant women and Moderate effect on lactating mothers. Further, the section on Symbiva 200 Octacap related warnings talks about Symbiva 200 Octacap's effects on the liver, heart and kidney.
Some other conditions that can be affected by Symbiva 200 Octacap are listed in the contraindications section below.
Additionally, Symbiva 200 Octacap may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Symbiva 200 Octacap is safe while driving, and is is addictive in nature.
Symbiva 200 Octacap is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Symbiva 200 Octacap safe for pregnant women?
Pregnant women may experience moderate side effects from Symbiva. It is best to stop taking Symbiva immediately and inform your doctor if you notice any discomfort.
Is the use of Symbiva 200 Octacap safe during breastfeeding?
Symbiva can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Symbiva 200 Octacap on the Kidneys?
There are no side effects of Symbiva on the kidneys.
What is the effect of Symbiva 200 Octacap on the Liver?
Symbiva does not damage the liver.
What is the effect of Symbiva 200 Octacap on the Heart?
Symbiva is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Symbiva 200 Octacap unless your doctor advises you to do so -
Is this Symbiva 200 Octacap habit forming or addictive?
No, you will not get addicted to Symbiva 200 Octacap.
Is it safe to drive or operate heavy machinery when consuming?
Symbiva 200 Octacap will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Symbiva 200 Octacap should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Symbiva 200 Octacap in mental disorders is not effective.
Interaction between Food and Symbiva 200 Octacap
Taking Symbiva 200 Octacap with food is safe.
Interaction between Alcohol and Symbiva 200 Octacap
Taking Symbiva 200 Octacap with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
Product Description [Internet]: SYMBICORT. AstraZeneca
